Literature DB >> 17717925

[Effects of tetramethylpyrazine on brain oxidative damage induced by intracerebral perfusion of L-DOPA in rats with Parkinson's disease].

Dan-qiao Wang1, Wei Wang, Fu-chun Jing.   

Abstract

OBJECTIVE: To observe the effects of tetramethylpyrazine (TMP) on brain oxidative damage induced by intracerebral perfusion of levodopa (L-DOPA) in rats with Parkinson's disease (PD).
METHODS: PD model rats were induced by intracerebral injection of 6-hydroxyl dopamine (6-OHDA) and perfused in brain with L-DOPA using microdialysis technique. Changes in levels of 2,3-dihydroxy benzyl acid (2.3-DHBA) and 2,5-dihydroxy benzyl acid (2,5-DHBA) in striatum of rats, formed by extracellular hydroxyl radical from salicylic acid capturing, were dynamically observed at various time points by HPLC-ED.
RESULTS: After treatment with L-DOPA, 2,3-DHBA and 2,5-DHBA in the model group showed significantly higher levels at 6 and 7 time points as compared with those in the sham-operated group at the corresponding time points (P <0.05 or P< 0.01), while these abnormal elevations were significantly inhibited in the TMP treated groups, either in large or small dose (P<0.05 or P<0.01).
CONCLUSION: TMP could reduce the L-DOPA induced brain oxidative damage in PD rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717925

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  5 in total

1.  Tetramethylpyrazine ameliorates depression by inhibiting TLR4-NLRP3 inflammasome signal pathway in mice.

Authors:  Songnian Fu; Jiangtao Wang; Chenguang Hao; Haihong Dang; Sheng Jiang
Journal:  Psychopharmacology (Berl)       Date:  2019-03-07       Impact factor: 4.530

2.  The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis.

Authors:  Daping Xu; Hongwei Duan; Zaijun Zhang; Wei Cui; Liang Wang; Yewei Sun; Ming Lang; Pui Man Hoi; Yifan Han; Yuqiang Wang; Simon MingYuen Lee
Journal:  J Neuroimmune Pharmacol       Date:  2014-03       Impact factor: 4.147

3.  Tetramethylpyrazine alleviated cytokine synthesis and dopamine deficit and improved motor dysfunction in the mice model of Parkinson's disease.

Authors:  Hong Zhao; Mei-Ling Xu; Qi Zhang; Zhao-Hui Guo; Ying Peng; Zheng-Yi Qu; Yong-Nan Li
Journal:  Neurol Sci       Date:  2014-07-17       Impact factor: 3.307

4.  Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.

Authors:  Haidy E Michel; Mariane G Tadros; Ahmed Esmat; Amani E Khalifa; Ahmed M Abdel-Tawab
Journal:  Mol Neurobiol       Date:  2016-08-11       Impact factor: 5.590

5.  Tetramethylpyrazine Produces Antidepressant-Like Effects in Mice Through Promotion of BDNF Signaling Pathway.

Authors:  Bo Jiang; Chao Huang; Xiang-Fan Chen; Li-Juan Tong; Wei Zhang
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-24       Impact factor: 5.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.